drugset / Trial / NCT00877370

Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis

NCT00877370

Phase 4 Completed 8 enrolled University of Michigan
NaSingle-groupOpen-label

Summary

Critically ill patients in the intensive care unit often receive continuous hemodialysis to treat their kidney failure. Ertapenem is an antibiotic often used in these patients. Continuous dialysis may remove ertapenem, putting patients at risk for inappropriate treatment of their infection. This study will determine how much ertapenem is removed by continuous hemodialysis.

Timeline

Start
2009-02
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ertapenem Small molecule 1 g Intravenous

Indications